Principal Financial Group Inc Cytek Biosciences, Inc. Transaction History
Principal Financial Group Inc
- $172 Billion
- Q4 2024
A detailed history of Principal Financial Group Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 506,925 shares of CTKB stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
506,925Holding current value
$2.61 Million% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding CTKB
# of Institutions
134Shares Held
72.2MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$87.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$60.7 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$48.9 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$34.3 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$21.5 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $693M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...